Yun Shin Chun

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. doi request reprint Defining venous involvement in borderline resectable pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 17:2832-8. 2010
  2. doi request reprint Significance of pathologic response to preoperative therapy in pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 18:3601-7. 2011
  3. doi request reprint Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases
    Yun Shin Chun
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA
    JAMA 302:2338-44. 2009
  4. doi request reprint Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry
    Yoji Kishi
    Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Ann Surg 250:540-8. 2009
  5. doi request reprint Is embolization of segment 4 portal veins before extended right hepatectomy justified?
    Yoji Kishi
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Surgery 144:744-51. 2008
  6. doi request reprint Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy
    Yoji Kishi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Ann Surg Oncol 16:614-22. 2009
  7. doi request reprint Impact of preoperative therapy on patterns of recurrence in pancreatic cancer
    Pavlos Papavasiliou
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    HPB (Oxford) 16:34-9. 2014
  8. doi request reprint Fibrolamellar variant of hepatocellular carcinoma
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Recent Results Cancer Res 190:101-10. 2013
  9. doi request reprint Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
    Yun Shin Chun
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 10:278-86. 2009
  10. doi request reprint Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer
    Alan A Thomay
    Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA
    J Gastrointest Surg 18:69-74. 2014

Collaborators

Detail Information

Publications12

  1. doi request reprint Defining venous involvement in borderline resectable pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 17:2832-8. 2010
    ..There is no consensus about what degree of venous impingement constitutes borderline resectability...
  2. doi request reprint Significance of pathologic response to preoperative therapy in pancreatic cancer
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Ann Surg Oncol 18:3601-7. 2011
    ..Pathologic response to preoperative therapy is increasingly recognized as an important prognostic factor in solid tumors. The impact of pathologic response on survival in pancreatic adenocarcinoma is not well established...
  3. doi request reprint Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases
    Yun Shin Chun
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA
    JAMA 302:2338-44. 2009
    ....
  4. doi request reprint Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry
    Yoji Kishi
    Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Ann Surg 250:540-8. 2009
    ..Secondary end point was to assess whether preoperative portal vein embolization (PVE) is associated with improved outcome in patients with initial sFLR ≤ 20%...
  5. doi request reprint Is embolization of segment 4 portal veins before extended right hepatectomy justified?
    Yoji Kishi
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Surgery 144:744-51. 2008
    ..However, whether segment 4 (S4) portal veins should be embolized is controversial. The effect of S4 PVE on the volume gain of segments 2 and 3 (S2+3) was examined...
  6. doi request reprint Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy
    Yoji Kishi
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Ann Surg Oncol 16:614-22. 2009
    ..Whether neutrophil-to-lymphocyte ratio (NLR) predicts survival of patients with colorectal liver metastases (CLM) treated with systemic chemotherapy remains unclear...
  7. doi request reprint Impact of preoperative therapy on patterns of recurrence in pancreatic cancer
    Pavlos Papavasiliou
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    HPB (Oxford) 16:34-9. 2014
    ..A theoretical advantage of preoperative therapy in pancreatic adenocarcinoma is that it facilitates the early treatment of micrometastases and reduces postoperative systemic recurrence...
  8. doi request reprint Fibrolamellar variant of hepatocellular carcinoma
    Yun Shin Chun
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Recent Results Cancer Res 190:101-10. 2013
    ..Despite complete surgical resection, relapse rates are high, and novel therapies are needed to prevent and treat recurrent disease...
  9. doi request reprint Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
    Yun Shin Chun
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 10:278-86. 2009
    ....
  10. doi request reprint Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer
    Alan A Thomay
    Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA
    J Gastrointest Surg 18:69-74. 2014
    ..In colorectal cancer, the involvement of regional lymph nodes with metastasis is an established prognostic factor. The impact of the number of positive nodes on patient outcome with stage IV disease is not well defined...
  11. doi request reprint Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases
    Dan G Blazer
    Department of Surgical Oncology, Gastrointestinal Medical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 26:5344-51. 2008
    ..The secondary goal of the study was to identify the clinical predictors of pathologic response...
  12. pmc The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery
    Pavlos Papavasiliou
    Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Int J Surg Oncol 2012:538769. 2012
    ..009). Conclusion. The first jejunal branch of the SMV has a highly variable course in relation to the SMA and has a higher incidence of an anterior location in this population than previously reported...